Jpmorgan Chase & CO Matinas Bio Pharma Holdings, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.15 - $0.37 $13 - $32	88 Added 0.19%	45,589 $7,000
Q1 2024 May 10, 2024	BUY	$0.19 - $0.3 $20 - $32	107 Added 0.24%	45,501 $12,000
Q4 2023 Feb 12, 2024	BUY	$0.12 - $0.64 $17 - $93	146 Added 0.32%	45,394 $9,000
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.41 $29 - $101	248 Added 0.55%	45,248 $5,000
Q3 2021 Nov 12, 2021	BUY	$0.67 - $1.51 $30,150 - $67,950	45,000 New	45,000 $59,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $124M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.